Scientists established a protocol for the induction of advanced liver fibrosis in rats using thioacetamide, which allowed to perform trials using MSC as a possible therapy for fibrosis regression.
[Analytical Cellular Pathology]
Home Newsletters Mesenchymal Cell News Model of Liver Fibrosis Induction by Thioacetamide in Rats for Regenerative Therapy...
